--- https://www.has-sante.fr/jcms/p_3304143/fr/lagevrio-molnupiravir https://www.has-sante.fr/jcms/p_3304251/fr/decision-n-2021-0313/dc/sem-du-9-decembre-2021-du-college-de-la-haute-autorite-de-sante-portant-refus-de-la-demande-d-acces-precoce-de-la-specialite-lagevrio-molnupiravir 2021 false false false France COVID-19 treatment outcome adult antiviral agents risk factors aged immunocompromised host administration, oral molnupiravir evaluation of the transparency committee molnupiravir
--- https://ansm.sante.fr/tableau-atu-rtu/lagevrio-200-mg-gelules 2021 false false false France French COVID-19 molnupiravir drug information severe COVID-19 molnupiravir